Euromonitor to Speak at Rx to OTC Switch Conference


Name: CBI’s Rx to OTC Switch Conference

Date: 4/20/16

Location: Princeton, NJ

Event Description: Pharmaceutical companies are considering switching their prescription drug to over-the-counter (OTC) status as patents continue to expire. To increase the chances of a successful switch, attend CBI’s 2nd Annual Rx to OTC Switch Summit and delve into the extensive drug development path. The switch process needs to be thorough and productive to ensure the potential switch candidate will be clinically safe and commercially viable.

Don’t miss the opportunity to network with industry trailblazers who have been involved with successful Rx to OTC switches and gain a deeper understanding of the important credentials to take your switch implementation strategy to the next level and gain market share.

Speaker: Monica Feldman, Head of Industry Research

Session Title: Redefining the Profile of the Consumer in Health – An Opportunity for Rx to OTC Switches

Synopsis: Self-care is seeing yet another big transformation amid the adoption of novel digital technology (smartphones, wearables and mobile medical devices) that will change how consumers empower themselves for better health so as to further Rx to OTC switches. This is just the tip of the iceberg where the concept of health optimization will bring new opportunities for the consumer health industry.

To sign up now, please visit or call (800) 222-8733. Be sure to include Promo Code SAVE400 to save $400.